CIK 0001761918 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Net income (USD) | -124.5 M | -125.0 M | -242.8 M |
| Diluted EPS (USD/shares) | -0.44 | -0.83 | -1.99 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-16 | 8-K | 8-K items 5.02 | 2026-10-15 |
| 2026-10-15 | 144 | 144 | |
| 2026-09-15 | 144 | 144 | |
| 2026-08-24 | 8-K | 8-K items 8.01 | 2026-08-24 |
| 2026-08-17 | 144 | 144 | |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-12 | 4 | 4 | 2026-08-10 |
| 2026-08-12 | 3 | 3 | 2026-08-10 |
| 2026-08-11 | S-8 | S-8 | |
| 2026-08-11 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-11 | 8-K | 8-K items 2.02,9.01 | 2026-08-11 |
| 2026-08-10 | 8-K | 8-K items 5.02 | 2026-08-10 |
| 2026-07-21 | 144 | 144 | |
| 2026-07-14 | 8-K | 8-K items 8.01,9.01 | 2026-07-13 |
| 2026-07-14 | 424B5 | 424B5 | |
| 2026-07-13 | 424B5 | 424B5 | |
| 2026-07-13 | 8-K | 8-K items 8.01 | 2026-07-13 |
| 2026-07-13 | S-3ASR | S-3ASR | |
| 2026-07-01 | 8-K | 8-K items 5.07 | 2026-06-26 |
| 2026-06-29 | 4 | 4 | 2026-06-26 |
| 2026-06-29 | 4 | 4 | 2026-06-26 |
| 2026-06-29 | 4 | 4 | 2026-06-26 |
| 2026-06-29 | 4 | 4 | 2026-06-26 |
| 2026-06-29 | 4 | 4 | 2026-06-26 |
| 2026-06-29 | 4 | 4 | 2026-06-26 |
Forms on file (last 1,000): 4 108, 8-K 60, 144 43, 10-Q 16, 3 15, SC 13G 13, SCHEDULE 13G/A 12, CORRESP 8. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=ERAS (0.002 USD), /gw/filings/filings?ticker=ERAS&form=8-K, /gw/filings/facts?ticker=ERAS&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange